Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:36:31.237Z.
Calculation as of: 2026-10-06T13:36:31.237Z.
Quote observation: 2026-10-06T13:34:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
EARNINGS YIELD
N/A
Market Cap
$194.51M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.12M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.08M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$175.27M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
Market Cap
$230.09M
Earnings Yield
N/A
TTM Avg
9.26%
3Y Avg
9.26%
5Y Avg
9.26%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $202.16M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $194.49M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $194.51M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $219.84M | 16.15% | 15.50% | 9.57% | 9.57% |
| Journey Medical Corporation (DERM)vs › | $184.12M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $177.91M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $175.27M | N/A | 12.15% | 12.15% | 12.15% |
| Keros Therapeutics, Inc. (KROS)vs › | $230.09M | N/A | 9.26% | 9.26% | 9.26% |
| Alector, Inc. (ALEC)vs › | $230.93M | N/A | 3.98% | 3.98% | 3.98% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
